Selvais SA
13.4 FTESelvais reported total assets of €1.75m at the end of the 2025 financial year (annual accounts filed with the NBB on 15 Jul 2026), with 13.4 full-time equivalents.
The score of Selvais shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -8 % Total assets +5 % Headcount (avg FTE) -1 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Selvais's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Jul 2026
- Year ended 31 Dec 2024filed on 10 Nov 2025
- Year ended 31 Dec 2023filed on 24 Jul 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 11 Jul 2022
Selvais's financial analysis
- Solvency46.8%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Selvais
Selvais's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0426.135.945
- VAT number
- BE0426135945
- Peppol
- Registered · 0208:0426135945 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 30 Aug 1984
- Registered office
- 6600 Bastogne
- Size
- Small · 13.4 FTE
- Latest accounts
- 2025 · filed on 15 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Selvais (SA) has been based in Bastogne since 1984, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 3,364 € and equity of 820,079 €; its revenue is not published. With 13.4 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 46.8%, above the median of its sector (41.5%).
Companies similar to Selvais
Companies in the same business, of comparable size and area, outside its group.
- Inge Thoelen Retail sale of pharmaceutical products Landen · balance sheet €1.74m
- Apotheek Luyten Retail sale of pharmaceutical products Nijlen · balance sheet €1.76m
- Hampharma Retail sale of pharmaceutical products Tessenderlo-Ham · balance sheet €1.75m
- Mooy Pharma Retail sale of pharmaceutical products Veurne · balance sheet €1.74m
- Apelec Retail sale of pharmaceutical products Zemst · balance sheet €1.74m
- Den Baksteen Retail sale of pharmaceutical products Asse · balance sheet €1.73m
- Pharmacie Gosselin-Obourg Retail sale of pharmaceutical products Mons · balance sheet €1.77m
- D4-Pharma Retail sale of pharmaceutical products Etterbeek · balance sheet €1.77m
Frequently asked questions about Selvais
What is the revenue of Selvais?
Selvais files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Selvais?
In Belgium, the VAT number is the company number prefixed with BE: BE0426135945 for Selvais, if the company is VAT-registered. Its company number (CBE) is 0426.135.945.
Where is the registered office of Selvais?
According to the CBE register, the registered office of Selvais is in 6600 Bastogne.
What is the equity of Selvais?
At the close of the 2025 financial year, the equity of Selvais amounts to 820,079 €, a solvency of 46.8% of total assets.
How many people work at Selvais?
13.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Selvais?
The register lists 5 active mandates at Selvais. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Selvais
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →